The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

The second person ever has received a transplant with a genetically modified pig kidney.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

A Massachusetts man suffering from end-stage kidney disease has become the second living person to receive a genetically modified pig kidney transplant, marking a major milestone in the field of ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration.

Using the gene-editing technique CRISPR, scientists can modify the pig’s DNA. eGenesis workers make more than 60 edits to help manage a host of potential issues including rejection, size of the organ ...

Massachusetts General Hospital announced Friday that Tim Andrews recovered well enough after the Jan. 25 transplant to leave ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...